Los puntos clave no están disponibles para este artículo en este momento.
Patients using glucagon-like peptide-1 receptor agonists are at increased risk of presenting for anaesthesia with residual gastric contents, though the available evidence does not indicate that this translates to an increased risk of pulmonary aspiration.
Elkin et al. (Tue,) studied this question.